CSO
Orum Therapeutics Appoints Chad May as Chief Scientific Officer
Orum Therapeutics; Chad May; CSO; Degrader-Antibody Conjugates; DAC; Targeted Protein Degradation
Ankyra Therapeutics Appoints Sailaja Battula, PhD as Chief Scientific Officer
Ankyra Therapeutics; Sailaja Battula; CSO appointment; immuno-oncology; biotechnology